These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 27842913)
1. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913 [TBL] [Abstract][Full Text] [Related]
2. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Pena I; Clayman GL; Grubbs EG; Bergeron JM; Waguespack SG; Cabanillas ME; Dadu R; Hu MI; Fellman BM; Li Y; Gross ND; Lai SY; Sturgis EM; Zafereo ME Head Neck; 2018 Jan; 40(1):79-85. PubMed ID: 29044788 [TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment. Krook KA; Fedewa SA; Chen AY Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center. Raue F; Bruckner T; Frank-Raue K J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454 [TBL] [Abstract][Full Text] [Related]
5. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years. James BC; Timsina L; Graham R; Angelos P; Haggstrom DA Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172 [TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma. Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144 [TBL] [Abstract][Full Text] [Related]
7. Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study. Tao Z; Deng X; Ding Z; Guo B; Fan Y Front Endocrinol (Lausanne); 2024; 15():1433329. PubMed ID: 39268233 [TBL] [Abstract][Full Text] [Related]
8. Impact of extensive neck dissection on survival from papillary thyroid cancer. Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375 [TBL] [Abstract][Full Text] [Related]
9. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. Kwon H; Kim WG; Sung TY; Jeon MJ; Song DE; Lee YM; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB J Surg Oncol; 2016 Feb; 113(2):152-8. PubMed ID: 26799259 [TBL] [Abstract][Full Text] [Related]
10. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer. Machens A; Lorenz K; Dralle H Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475 [TBL] [Abstract][Full Text] [Related]
11. Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching. Tao Z; Deng X; Ding Z; Guo B; Fan Y Sci Rep; 2024 Jul; 14(1):17260. PubMed ID: 39068197 [TBL] [Abstract][Full Text] [Related]
12. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer. Roche AM; Fedewa SA; Chen AY JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period. Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740 [TBL] [Abstract][Full Text] [Related]
14. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer. Papaleontiou M; Hughes DT; Guo C; Banerjee M; Haymart MR J Clin Endocrinol Metab; 2017 Jul; 102(7):2543-2551. PubMed ID: 28460061 [TBL] [Abstract][Full Text] [Related]
15. Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer. Liu CQ; Shen CK; Du YX; Li ZM; Shi X; Wang Y; Wei WJ J Clin Endocrinol Metab; 2024 Oct; 109(11):2979-2985. PubMed ID: 38570918 [TBL] [Abstract][Full Text] [Related]
16. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Goffredo P; Cheung K; Roman SA; Sosa JA Ann Surg Oncol; 2013 Mar; 20(3):767-72. PubMed ID: 23111705 [TBL] [Abstract][Full Text] [Related]
17. Surgical management of medullary thyroid cancer: which guidelines should we follow? Bowen A; Mani N; Penney S; Loughran S; Yap B J Laryngol Otol; 2015 May; 129(5):478-83. PubMed ID: 25994382 [TBL] [Abstract][Full Text] [Related]
18. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258 [TBL] [Abstract][Full Text] [Related]
19. Association between age and disease specific mortality in medullary thyroid cancer. Sahli ZT; Canner JK; Zeiger MA; Mathur A Am J Surg; 2021 Feb; 221(2):478-484. PubMed ID: 33010878 [TBL] [Abstract][Full Text] [Related]
20. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases. Verburg FA; Mäder U; Luster M; Reiners C Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]